Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Dermatology Board Prep > DERM (18) Skin Growths > Other lymphoproliferative and myeloproliferative diseases > Flashcards

Other lymphoproliferative and myeloproliferative diseases Flashcards

1
Q

What cancer is most commonly associated with leukemia cutis?

A

AML

Usually, there is proceeding marrow and peripheral blood involvement but you can have aleukemic leukemia cutis as well

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the clinical appearance of leukemia cutis?

A

Violaceous papules and nodules at any location. Note these can have a green appearance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What subforms of AML are most associated with leukemia cutis?

A

Myelomonocytic and monocytic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the histology of leukemia cutis?

A

Grenz zone

  • diffuse dermal infiltrate of myeloid blasts
  • These cells are monotonous and w/ high nuclear to cytoplasm ratio and fine chromatin.
  • Can look like they are in sheets, nodules, perivascularly or infiltrative cords (Indian filing)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the most common staining for leukemia cutis?

A

MPO+, CD117 (c-kit)+, CD13+, CD33+, and CD34+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the name of the green appearing nodules in the setting of AML?

A

Chloroma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the cause of the green appearance in a chloroma?

A

Myeloperoxidase activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the differential diagnosis for red indurated plaques involving the face?

A

Lupus erythematosus, PMLE, Lymphoma Cutis, Lymphocytoma cutis, Jessner’s lymphocytic infiltrate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the clinical appearance of Jessner’s lymphocytic infiltrate?

A

1 or several asymptomatic erythematous papules,
plaques, and less commonly, nodules, with the absence of secondary changes like scale on head, neck, and upper back

May appear as annular plaque with central clearing if individual lesion

No associated systemic manifestations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the treatment of Jessner’s Lymphocytic Infiltrate?

A

Resolves spontaneously within months to years, without scarring or sequelae

50% pts may improve with hydroxychloroquine

Thalidomide, pulsed dye (595 nm) laser, chemotherapy as other options

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the histology of Jessner’s lymphocytic infiltrate?

A

Superficial and deep perivascular and periadnexal lymphocytic infiltrate

interface dermatitis is absent

predominance of CD8+ lymphocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the cause of cutaneous lymphoid hyperplasia?

A

Reflects exaggerated local immunologic reaction to a stimulus, often unrecognized

Inciting agents: arthropod bites, metal implants, tattoos, vaccinations and medications as well as several infections and reactive disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the clinical appearance of cutaneous lymphoid hyperplasia?

A

Firm, erythematous to violaceous papules, plaques or nodules located on head, neck or upper extremities

Often solitary but may be multiple and grouped

Vast majority lack surface changes

Most often in adults; slightly more common women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What can cutaneous lymphoid hyperplasia also be called?

A

Pseudolymphoma (can resemble lymphoma or have a more benign appearance)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the treatment for cutaneous lymphoid hyperplasia?

A

Treat conservatively, spontaneous resolution may occur without scarring; topical or IL steroids for persistent lesions; simple excision, cryosurgery, laser ablation, and radiation therapy; thalidomide for recalcitrant cases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What type of leukemia is most often associated with neutrophilic disorders (Sweet’s, pyderma gangrenosum, and neutrophilic eccrine hidradenitis?

A

AML

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

In what leukemias can you see exaggerated arthropod reactions or erythroderma?

A

CLL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the most common leukemia associated with polyarteritis nodosa, vasculitis (small vessel/leukocytoclastic), erythema elevatum diutinum?

A

Hairy cell leukemia

19
Q

What leukemias are most commonly associated w/ erythema nodosum?

A

AML, CML, CMML

20
Q

What are the leukemias most associated with other panniculitides aside from erythema nodosum?

A

Hairy cell leukemia, AML, CMML

21
Q

What leukemia is most commonly associated with erythema multiforme?

A

CLL

22
Q

What leukemias are most commonly associated with urticarial?

A

CLL, hairy cell leukemia

23
Q

What is the immunophenotype ALL?

A

Most commonly TDT+, CD5+, CD19+, CD20+, CD10+ B-cell)

Can rarely be T-cell related as well (TDT+, Cd1a+, CD2+, CD3c+, CD5+, CD7+)

24
Q

What is the immunophenotype of CLL?

A

CD5+, CD20+, CD43+ (B-cell types)

25
Q

What is the most common immunophenotype of AML?

A

AMML most common (M4 and AMol (M5) =

CD13+, CD33+, CD68+, MPO+

26
Q

What stain can be helpful in diagnosing leukemia cutis?

A

Leder stain (can identify the atypical cells as myeloid)

27
Q

What is the prognostic significance of leukemia cutis?

A

Poor prognostic finding. 90% of patients have extramedullary involvement and 40% have meningeal infiltration

28
Q

In what setting does cutaneous Hodgkin’s occur in?

A

Advanced systemic dz and is a marker of poor prognosis

29
Q

What is the most specific stain for Hodgkin lymphoma?

A

Pax-5

30
Q

What is the clinical appearance of cutaneous Hodgkin lymphoma?

A

Isolated cutaneous HD presents as 1 or several papules, plaques, or ulcerated nodules with no site predilection

MC presentation is multiple, disseminated papulonodules and plaques appearing rapidly in pt with known, advanced disease

Often distal to affected lymph nodes

Trunk most common site

20-50% pts can have paraneoplastic cutaneous disorders like primary pruritus, acquired ichthyosis, persistent dermatitis, hyperpigmentation, and erythema nodosum

31
Q

What are the other systemic cutaneous findings can occur in Hodkin’s lymphoma?

A

20-50% pts can have paraneoplastic cutaneous disorders like primary pruritus, acquired ichthyosis, persistent dermatitis, hyperpigmentation, and erythema nodosum

32
Q

What is the histology of Hodgkin lymphoma?

A

Dermal infiltrate consistent of lymphocytes with occasional eosinophils and plasma cells present

Reed-Sternberg cells and lacunar cells (large cells with abundant eosinophilic cytoplasm) may be present depending on subtype

33
Q

What is the clinical appearance of blastic plasmacytoid dendritic cell neoplasm?

A

Adults usually >50 y/o

-Male-to-female ratio 3:1

solitary or multiple, non-tender, variably pruritic, erythematous to violaceous papules, plaques or nodules

Skin is presenting site of involvement in 50% pts

May have subclinical regional lymph node, peripheral blood and bone marrow involvement

34
Q

What is the pathology of blastic plasmacytoid dendritic cell neoplasm?

A

Diffuse dermal infiltrate of monotonous, atypical, medium-sized mononuclear cells

Fine blastic chromatin, indistinct nucleoli and scant granular eosinophilic cytoplasm

Numerous mitoses

Grenz zone

Infiltrate commonly extends to subcutis

Immunohistochemical studies: CD4+, CD56+, CD123+, TCL1+, BDCA2+, MPO-, TCL1+ 90% cases

35
Q

What is the immunophenotype of blastic plasmacytoid dendritic cell neoplasm?

A

CD4+, CD56+, CD123+, TCL1+, BDCA2+, MPO-, TCL1+ 90% cases

36
Q

What are the 5 histologic patterns of angioimmunoblastic T-cell lymphoma?

A
  1. Superficial perivascular infiltrate composed of eos and lymphocytes that lack atypia (MC)
  2. Sparse perivascular infiltrate with atypical lymphocytes
  3. Dense superficial and deep infiltrate of pleomorphic lymphocytes
  4. Vasculitis with or without atypical lymphocytes
  5. Necrotizing granulomas
37
Q

What is the clinical presentation of angioimmunoblastic T-cell lymphoma?

A
  • constitutional sx’s: fever, sweats, weight loss)
  • Variable morphology: morbilliform erythema, urticaria, and rarely erythroderma
  • Can have generalized LAD and hepatosplenomegaly
38
Q

What infection is lymphomatoid granulomatosis related to?

A

EBV infection sometimes w/ immunosuppression (think renal transplant, Wiskott-Aldrich, HIV, x-linked lymphoproliferative syndrome

39
Q

What is the epidemiology of lymphomatoid granulomatosis?

A

Adults, 5-6th decade, male to female ratio 2:1

40
Q

What are the most prominent cell seen on histology in lymphomatoid granulomatosis?

A

T-cells! Even though it is a b-cell process there is a reactive process that is more prominent than the underlying dz

41
Q

What are the clinical features of lymphomatoid granulomatosis

A

Sxs related to pulmonary involvement – cough, dyspnea, and chest pain (common presenting)

Constitutional sxs like fever, weight loss, malaise, arthalgias and myalgias

Cutaneous lesions in 25-50% pts – nodules or ulcerated plaques

May affect kidney, brain, and GI

Lymph node and spleen rarely involved

42
Q

What is the histopathology of lymphomatoid granulomatosis?

A

Nodular lymphoid infiltrates composed of lymphocytes, plasma cells and large atypical mononuclear cells with convoluted nuclei and prominent nucleoli

Often surround and invade arteries and veins

Granulomatosis is distinct prominent feature – necrosis within lymphoid aggregates in absence of granuloma formation

+CD20, +CD79a, +EBV DNA

43
Q

Immunophenotype in lymphomatoid granulomatosis?

A

+CD20, +CD79a, +EBV DNA

44
Q

What is the treatment of lymphomatoid granulomatosis?

A

Aggressive; 60-90% 5-year mortality; multidrug chemo and/or rituximab; IFN-alpha for milder cases; reversal of exogenous immunosuppression may lead to clinical improvement

DERM (18) Skin Growths (17 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions